Independent Conference Coverage: Expert Analyses of Atopic Dermatitis Research Results and Their Potential Impact on Patient Care *

AAAAI February 26 - March 1, 2021, AAD VMX April 23-25, 2021; Virtual
Review the latest AD management data with Capsule Summaries and gain expert insights from a brief commentary covering key studies from the 2021 AAAAI and AAD conferences.

Share

Program Content

4 Capsule Summary Slidesets

Activities

Skin Pain in Children With AD
Analysis of Skin Pain in Children With Atopic Dermatitis
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 11, 2021

Expires: June 10, 2022

JADE COMPARE Analysis
JADE COMPARE Analysis: Defining the Depth and Rapidity of Response of Abrocitinib and Dupilumab in Patients With Moderate to Severe Atopic Dermatitis
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 15, 2021

Expires: June 14, 2022

Ruxolitinib Cream for AD
Rapid Decrease in Pruritus With Ruxolitinib Cream for Patients With Atopic Dermatitis: Pooled Results From TRuE-AD1 and TRuE-AD2
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 18, 2021

Expires: June 17, 2022

Dupilumab Facial Redness
Azoles for the Treatment of Patients Developing Dupilumab Facial Redness
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: June 10, 2021

Expires: June 09, 2022

Activities

New Data in AD
My Take on New Data in Atopic Dermatitis
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: June 30, 2021

Expires: June 29, 2022

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Incyte Corporation

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.